• Author: Gary A. Kunkel
Clear all

Mortality in US Veterans with rheumatoid arthritis treated with immune checkpoint inhibitors

Abstract: Objective: This investigation compared all-cause and cause-specific mortality in patients with and without rheumatoid arthritis (RA) in the Veterans Health Administration …

Antibodies to malondialdehyde-acetaldehyde adduct are associated with prevalent and incident rheumatoid arthritis-associated interstitial lung disease in US Veterans

Abstract: Objective: To determine the associations of protein-specific anti-malondialdehyde acetaldehyde (MAA) antibodies with prevalent and incident rheumatoid …

Missed opportunities for treatment of inflammatory arthritis and factors associated with non-treatment: An observational cohort study in United States Veterans with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis

Abstract: Objective: To identify factors associated with non-treatment with biologic and non-biologic disease modifying anti-rheumatic drugs (DMARDs) during the 12 months after …

Lowering expectations: glucocorticoid tapering among Veterans with rheumatoid arthritis achieving low disease activity on stable biologic therapy

Abstract: Objective: In the Steroid EliMination In Rheumatoid Arthritis (SEMIRA) trial, 65% of patients with rheumatoid arthritis (RA) in low disease activity (LDA) on stable …

A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National Matched Cohort Study in US Veterans With Rheumatoid Arthritis

Codebeautify.org Text to HTML Converter Abstract: To examine temporal trends in all-cause and cause-specific mortality in patients with rheumatoid arthritis (RA) in the Veterans …

The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease

Abstract: To determine whether RA and interstitial lung disease (ILD) severity measures are associated with survival in patients with RA-ILD. We studied US veterans with RA-ILD …